Sofinnova Healthquest Partners
SlowingMenlo Park, CAHealthcare, Pharmaceuticals, BiotechnologyLast fund filed July 2013
1 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Sofinnova HealthQuest Partners, L.P. | July 2013 | $110M | $65M | 26 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
1 partner is named across this firm’s filings, 1 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Garheng Kong | Slowing | Medical devices, Biotech & pharma, Healthcare services | 17 |
Classified sectors of Sofinnova Healthquest Partners’s own portfolio companies, based on 16 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Sofinnova Healthquest Partners’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Domain Partners | 2 | ALIMERA SCIENCES, Trice Medical |
| Polaris Partners | 2 | Ajax Health III, Nomad Health |
| Abingworth Bioventures | 1 | AVEDRO |
| Bessemer Venture |
| 1 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| 1 |
| Alcresta Therapeutics |
| Bessemer Venture Associates XIII | 1 | Alcresta Therapeutics |
| Bessemer Venture Partners | 1 | Alcresta Therapeutics |
| Bessemer Venture Partners India | 1 | Alcresta Therapeutics |
| Borealis | 1 | AVEDRO |
| Caduceus Capital | 1 | AVEDRO |
| First Round Capital | 1 | Nomad Health |
| Flare Capital | 1 | Home Hospital Newco |
| Icon Ventures | 1 | Nomad Health |
| Longitude Capital | 1 | Venus Concept |
| Orbimed Asia Partners | 1 | AVEDRO |
| Orbimed Genesis | 1 | AVEDRO |
A shared board seat: a company where filings name a Sofinnova Healthquest Partners partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.